University Rehabilitation Institute, Republic of Slovenia
Ljubljana, 1000, Slovenia
NCT Number: NCT07654335
The study will investigate safety, usability, feasibility and preliminary efficacy of perturbation-based training in participants post-stroke and older adults with mild balance deficits. Both group will receive three weks of training. The primary outcome measure will be derived from laboratory-induced falls.
Trial opening soon.
Get Notified18 year–75 year
All sexes
Interventional
Not applicable
Ljubljana, 1000, Slovenia
Two convenience samples will be recruited to serve as self-controls, 20 post-stroke adults and 30 community-dwelling older adults. Participants post stroke will be recruited after discharge from their regular rehabilitation. Each subject will undergo individually customised perturbation-based training sessions with safety harnesses. The participants will be assessed at four time points: at baseline, after 3 weeks (at the beginning of training), at the end of 3-week training, and at 3-week follow-up. Safety, usability and efficacy of training will be evaluated using slip-, trip- and platform-movement-based perturbations induced by a Stewart platform and dual-belt treadmill, whereby the perturbation strength that can be reliably counteracted will be recorded, and using standardised clinical outcome measures.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for both arms:
Exclusion criteria
for both arms:
Additional Inclusion Criteria for post-stroke patients:
Additional Inclusion Criteria for older adults:
Each subject will undergo 9 perturbation-based training sessions with safety harnesses, and the device will deliver waist pulls during treadmill walking. Training sessions will be individually customised. Perturbation intensity will be progressively increased by a physiotherapist according to the subject's abilities. Training sessions will last approximately 30 minutes, 2-3 times per week.
Other names: PACE-R
Time frame: Difference between the two assessments - one day before the first and one day after the last training session
Perturbation strength that can be reliably counteracted - difference score (minimum 0N, no upper limit, stronger perturbation means better outcome, larger difference means better outcome)
Time frame: Difference between the two assessments - one day before the first and one day after the last training session
Mini Balance Evaluation Systems Test - difference score (score range 0-28, higher score means better outcome, larger difference means better outcome)
Time frame: Difference between the two assessments - one day before the first and one day after the last training session
Activities-Specific Balance Confidence Scale - difference score (score range 0%-100%, higher score means better outcome, larger difference means better outcome)
Time frame: During all the nine training sessions across the three weeks
Number of adverse events (fatigue, pain, secured falls) during training (fewer events mean better outcome)
Contact information is provided by the study sponsor or research team.
University Rehabilitation Institute, Republic of Slovenia
Other
Experimental Perturbation-based-training Study in Patients After Stroke and Older Adults
Acronym: PACE-R
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03288220
Aging, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03366129
Aging, Brain Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07624630
Aging, Brain Diseases
Solna, Stockholm County, Sweden
View Trial DetailsNCT04287283
Aging, Brain Diseases
Rishon LeZiyyon, Israel
View Trial Details